The Challenge
Life sciences companies, while adept at identifying opportunities using claims data, often lack the granularity needed to support precise decision-making.
Introducing last mile patient and provider information enhances existing claims datasets for greater ROI.
Why Trio Health CATALYST?
Our approach sets Trio Health apart from conventional EHR data providers. We offer:
- Clinical Insights from a Community setting
Trio merges EHR nightly updates with real-time EHR access, offering a live holistic view of the patient journey
- Real-Time Surveillance
Our Clinical Scribes deliver discontinuation reasons and critical insights within 24 hours of patient visits, transforming data into immediate action
- Physician & Patient Access
Trio has direct access to physicians and patients through our ecosystem enabling real-world interventions and evidence-based decision-making
Did you know?
in Rheumatoid Arthritis:
43% of RA patients in the Trio Health registry discontinued their biologic therapy due to clinically manageable symptoms.
in Hereditary Angioedema:
Trio developed proprietary levels of evidence for ensuring an accurate HAE diagnosis for every HAE patient in our registry and diagnosis is confirmed by the treating physician.
in Asthma:
44% of discontinuations in the Trio registry had an ACT or FEV1 score within 30 days prior to discontinuation and 62% of these patients had a score indicating controlled asthma.
Interested in learning more about our covered disease areas?
CONTACT OUR TEAM TODAY
Fit-for-purpose patient-level data in a ready to analyze format
Discover how Catalyst can enhance your data strategy and real-world patient insights.
Download our solutions eBook
What's inside
-
Trio solutions by use case
-
A look into our proprietary patient registries
-
Hereditary Angioedema Patient Registry Sample Data
-
Rheumatoid Arthritis Patient Registry Sample Data
-
Moderate & Severe Asthma Patient Registry Sample Data
